Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IKANOS: Breztri vs Non-Triple Therapy in COPD Exacerbation
NCT05970263Phase 4Withdrawn
- Sponsor
- AstraZeneca
- Start
- Jan 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of Breztri Aerosphere in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Planned start Jan 2024; status: withdrawn.
02
Drugs
Breztri Aerosphere
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT05970263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05970263.